Image-01 (F7e712aa B1bf 4ecd 8d72 2b1cb68611ce 01)
Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 68180-339
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 68180-339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-02 (F7e712aa B1bf 4ecd 8d72 2b1cb68611ce 02)
NDC 68180-338-01 is a medicine containing Metformin Hydrochloride in extended-release tablets form. It should be dispensed by a pharmacist with a patient information leaflet provided separately to each patient. Each coated extended-release tablet contains 500 mg of the active ingredient. Dosage information can be found in the package insert for prescribing information. It's important to keep the medication out of the reach of children and store it at controlled room temperature. It was manufactured by Lupin Pharmaceuticals, Inc. in Baltimore and by Lupin Limited in India.*
Image-03 (F7e712aa B1bf 4ecd 8d72 2b1cb68611ce 03)
This is prescribing information for an extended-release tablet containing metformin with a National Drug Code of 68180-339-09. The tablet should be kept out of reach of children and stored at room temperature between 25°C to 30°C (59°F to 86°F). It is manufactured by Lupin Limited in Goa, India. The tablets should be dispensed separately to each patient and taken once daily. The text suggests a bottle contains 90 tablets, and the reference number is Rxonly 10320 mm.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
